XML 49 R36.htm IDEA: XBRL DOCUMENT v3.22.0.1
Fair Value Measurement (Tables)
 12 Months Ended
Dec. 31, 2021
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
The following table provides a reconciliation of our Level 3 earn-out liabilities measured at estimated fair value based on an initial valuation and updated quarterly for the years ended December 31, 2021, 2020 and 2019 (in thousands):
Earn-out Liability
Contingent earn-out liability, January 1, 2019$47,400 
Acquisition date fair value estimate of earn-out(1)
17,300 
Change in fair value of contingent earn-out (included in income from operations as a separate line item)(2)
(47,400)
Contingent earn-out liability, December 31, 2019$17,300 
Change in fair value of contingent earn-out (included in income from operations as a separate line item)(3)
9,000 
Contingent earn-out liability, December 31, 2020$26,300 
Contingent earn-out — non-compete arrangement2,589 
Transfer of Pursuit earn-out liability into Level 2(4)
(26,300)
Contingent earn-out liability, December 31, 2021$2,589 
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]
Our assets and liabilities measured at fair value on a recurring basis consisted of the following (Level 1, 2 and 3 inputs as defined above) (in thousands): 
 Fair value measurements as of December 31, 2021
 Total carrying
value		Quoted prices
in active
markets for
identical
assets (level 1)		Significant
other
observable
inputs (level 2)		Significant
unobservable
inputs (level 3)
Assets:
Available-for-sale debt securities:
Short-term$14,420 $— $14,420 $— 
Long-term4,620 — 4,620 — 
Foreign exchange forwards:
Prepaid expenses and other current assets1,061 — 1,061 — 
Total Assets$20,101 $— $20,101 $— 
Liabilities:
Contingent earn-out liability - LT$2,589 $— $— $2,589 
Forward-starting interest rate swaps:
Other long-term liabilities1,480 — 1,480 — 
Total Liabilities$4,069 $— $1,480 $2,589 
  
 Fair value measurements as of December 31, 2020
 Total carrying
value		Quoted prices
in active
markets for
identical
assets (level 1)		Significant
other
observable
inputs (level 2)		Significant
unobservable
inputs (level 3)
Assets:
Available-for-sale debt securities:
Short-term$14,687 $— $14,687 $— 
Long-term12,974 — 12,974 — 
Foreign exchange forwards:
Prepaid expenses and other current assets3,555 — 3,555 — 
Total Assets$31,216 $— $31,216 $— 
Liabilities:
Earn-out liability$26,300 $— $— $26,300 
Total Liabilities$26,300 $— $— $26,300 
Hospira [Member]  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] The following table provides quantitative information about Level 3 inputs for fair value measurement of the Pursuit earn-out liability as of the acquisition date to December 31, 2020:
Pursuit Vascular, Inc. [Member]  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]
Pursuit Earn-out
As of
December 31, 2020		At Acquisition
November 2, 2019
Simulation Input
Revenue/Gross Profit Volatility25.00 %20.00 %
Discount Rate12.50 %15.00 %
Risk-free rate0.09 %1.55 %
Counter Party Risk3.10 %6.00 %